article thumbnail

Researchers Propose Solutions to Improve GLP-1 RA Access

Physician's Weekly

“Society all too often conceptualizes obesity as a problem of individual willpower, which could reduce the demand for pharmacological treatments among those who are most affected and who have the potential for greatest benefit,” the researchers said.

article thumbnail

The MAHA Assessment’s Implications: Drugs (Part One)

FDA Law Blog

The Strategy must address appropriately restructuring the Federal Governments response to the childhood chronic disease crisis, including by ending Federal practices that exacerbate the health crisis or unsuccessfully attempt to address it, and by adding powerful new solutions that will end childhood chronic disease.